MarketBeat Instant News Alerts 2 hours agoPfizer Inc. (NYSE:PFE) Plans $0.43 Quarterly DividendMarketBeatPfizer Inc. (NYSE:PFE) declared a quarterly dividend on Thursday, October 9th. Shareholders of record on Friday, November 7th will be given a dividend of 0.43 per share by the biopharmaceutical company on Monday, December 1st. This represents a c) annualized dividend and a dividend yield of 6.8%. NYSE:PFERead Pfizer Inc. (NYSE:PFE) Plans $0.43 Quarterly Dividend2 hours agoMP Materials (NYSE:MP) Shares Gap Up - Here's WhyMarketBeatMP Materials (NYSE:MP) Shares Gap Up - Here's What HappenedNYSE:MPRead MP Materials (NYSE:MP) Shares Gap Up - Here's Why2 hours agoTeraWulf (NASDAQ:WULF) Shares Gap Up - Here's WhyMarketBeatTeraWulf (NASDAQ:WULF) Shares Gap Up - Still a Buy?NASDAQ:WULFRead TeraWulf (NASDAQ:WULF) Shares Gap Up - Here's Why2 hours agoEnergy Fuels (NYSEAMERICAN:UUUU) Shares Gap Up - Should You Buy?MarketBeatEnergy Fuels (NYSEAMERICAN:UUUU) Shares Gap Up - Here's WhyNYSEAMERICAN:UUUURead Energy Fuels (NYSEAMERICAN:UUUU) Shares Gap Up - Should You Buy?2 hours agoServe Robotics (NASDAQ:SERV) Shares Gap Up - What's Next?MarketBeatServe Robotics (NASDAQ:SERV) Shares Gap Up - Still a Buy?NASDAQ:SERVRead Serve Robotics (NASDAQ:SERV) Shares Gap Up - What's Next?2 hours agoARQ (NASDAQ:ARQ) Earns Sell (D-) Rating from Weiss RatingsMarketBeatWeiss Ratings restated a "sell (d-)" rating on shares of ARQ in a research note on Wednesday.NASDAQ:ARQRead ARQ (NASDAQ:ARQ) Earns Sell (D-) Rating from Weiss Ratings Trending News1D-Wave Quantum (NYSE:QBTS) Downgraded to "Strong Sell" Rating by Zacks Research2Quantum Computing Stocks To Keep An Eye On - October 7th3Zacks Research Issues Pessimistic Outlook for NIO Earnings4AST SpaceMobile, Inc. $ASTS Shares Sold by 111 Capital5Kraken Robotics (CVE:PNG) Sets New 12-Month High - What's Next?6IonQ (NYSE:IONQ) Shares Down 4.3% - Here's What Happened7MBL Wealth LLC Makes New $591,000 Investment in Solid Power, Inc. $SLDP8DraftKings (NASDAQ:DKNG) Shares Down 4.7% Following Analyst Downgrade All MarketBeat Instant News Alerts Latest News Trending News Sort By Last 24 Hours Last 3 Days Last 7 Days Last 14 Days Last 30 Days Last 90 Days All Time Time Frame All Alerts Analyst Congressional Trades Consensus Corporate Buyback Dividend Earnings Earnings Preview Estimates Guidance Insider Trade Lockup Expiration Options Price SEC Filing Stock List Stock Split Alert Type Keywords 2 hours agoArmstrong World Industries' (AWI) Buy (B) Rating Reiterated at Weiss RatingsMarketBeatNYSE:AWIRead Armstrong World Industries' (AWI) Buy (B) Rating Reiterated at Weiss Ratings2 hours agoArhaus (NASDAQ:ARHS) Receives "Hold (C)" Rating from Weiss RatingsMarketBeatNASDAQ:ARHSRead Arhaus (NASDAQ:ARHS) Receives "Hold (C)" Rating from Weiss Ratings2 hours agoWeiss Ratings Reaffirms Hold (C) Rating for argenex (NASDAQ:ARGX)MarketBeatNASDAQ:ARGXRead Weiss Ratings Reaffirms Hold (C) Rating for argenex (NASDAQ:ARGX)2 hours agoAres Capital (NASDAQ:ARCC) Given Buy (B) Rating at Weiss RatingsMarketBeatNASDAQ:ARCCRead Ares Capital (NASDAQ:ARCC) Given Buy (B) Rating at Weiss Ratings2 hours agoWeiss Ratings Reaffirms "Sell (D-)" Rating for Ardelyx (NASDAQ:ARDX)MarketBeatNASDAQ:ARDXRead Weiss Ratings Reaffirms "Sell (D-)" Rating for Ardelyx (NASDAQ:ARDX)2 hours agoArcturus Therapeutics (NASDAQ:ARCT) Receives "Sell (D-)" Rating from Weiss RatingsMarketBeatNASDAQ:ARCTRead Arcturus Therapeutics (NASDAQ:ARCT) Receives "Sell (D-)" Rating from Weiss Ratings2 hours agoWeiss Ratings Reiterates "Hold (C+)" Rating for Arch Capital Group (NASDAQ:ACGL)MarketBeatNASDAQ:ACGLRead Weiss Ratings Reiterates "Hold (C+)" Rating for Arch Capital Group (NASDAQ:ACGL)2 hours agoArcellx's (ACLX) "Sell (D-)" Rating Reaffirmed at Weiss RatingsMarketBeatNASDAQ:ACLXRead Arcellx's (ACLX) "Sell (D-)" Rating Reaffirmed at Weiss Ratings2 hours agoWeiss Ratings Reiterates Hold (C-) Rating for ArcBest (NASDAQ:ARCB)MarketBeatNASDAQ:ARCBRead Weiss Ratings Reiterates Hold (C-) Rating for ArcBest (NASDAQ:ARCB)2 hours agoArbutus Biopharma (NASDAQ:ABUS) Receives "Sell (D-)" Rating from Weiss RatingsMarketBeatNASDAQ:ABUSRead Arbutus Biopharma (NASDAQ:ABUS) Receives "Sell (D-)" Rating from Weiss Ratings2 hours agoArbe Robotics (NASDAQ:ARBE) Given "Sell (E+)" Rating at Weiss RatingsMarketBeatNASDAQ:ARBERead Arbe Robotics (NASDAQ:ARBE) Given "Sell (E+)" Rating at Weiss Ratings2 hours agoWeiss Ratings Reiterates Sell (D-) Rating for Aquestive Therapeutics (NASDAQ:AQST)MarketBeatNASDAQ:AQSTRead Weiss Ratings Reiterates Sell (D-) Rating for Aquestive Therapeutics (NASDAQ:AQST)2 hours agoApyx Medical's (APYX) Sell (E+) Rating Reaffirmed at Weiss RatingsMarketBeatNASDAQ:APYXRead Apyx Medical's (APYX) Sell (E+) Rating Reaffirmed at Weiss Ratings2 hours agoAptarGroup (NYSE:ATR) Cut to "Hold (C+)" at Weiss RatingsMarketBeatNYSE:ATRRead AptarGroup (NYSE:ATR) Cut to "Hold (C+)" at Weiss Ratings2 hours agoWeiss Ratings Reaffirms Sell (D-) Rating for Applied Optoelectronics (NASDAQ:AAOI)MarketBeatNASDAQ:AAOIRead Weiss Ratings Reaffirms Sell (D-) Rating for Applied Optoelectronics (NASDAQ:AAOI)2 hours agoAppian's (APPN) "Sell (D-)" Rating Reiterated at Weiss RatingsMarketBeatNASDAQ:APPNRead Appian's (APPN) "Sell (D-)" Rating Reiterated at Weiss Ratings2 hours agoAppFolio (NASDAQ:APPF) Receives "Buy (B-)" Rating from Weiss RatingsMarketBeatNASDAQ:APPFRead AppFolio (NASDAQ:APPF) Receives "Buy (B-)" Rating from Weiss Ratings2 hours agoApogee Therapeutics' (APGE) "Sell (D-)" Rating Reiterated at Weiss RatingsMarketBeatNASDAQ:APGERead Apogee Therapeutics' (APGE) "Sell (D-)" Rating Reiterated at Weiss Ratings2 hours agoApogee Enterprises' (APOG) Hold (C-) Rating Reaffirmed at Weiss RatingsMarketBeatNASDAQ:APOGRead Apogee Enterprises' (APOG) Hold (C-) Rating Reaffirmed at Weiss Ratings2 hours agoWeiss Ratings Reiterates Sell (E+) Rating for Apellis Pharmaceuticals (NASDAQ:APLS)MarketBeatNASDAQ:APLSRead Weiss Ratings Reiterates Sell (E+) Rating for Apellis Pharmaceuticals (NASDAQ:APLS)2 hours agoAnterix's (ATEX) "Sell (D+)" Rating Reaffirmed at Weiss RatingsMarketBeatNASDAQ:ATEXRead Anterix's (ATEX) "Sell (D+)" Rating Reaffirmed at Weiss Ratings2 hours agoAnteris Technologies Global (NASDAQ:AVR) Earns Sell (E+) Rating from Weiss RatingsMarketBeatNASDAQ:AVRRead Anteris Technologies Global (NASDAQ:AVR) Earns Sell (E+) Rating from Weiss Ratings2 hours agoBlack Diamond Group (TSE:BDI) Hits New 52-Week High - Still a Buy?MarketBeatTSE:BDIRead Black Diamond Group (TSE:BDI) Hits New 52-Week High - Still a Buy?2 hours agoFirst Trust Large Cap Growth AlphaDEX Fund (NASDAQ:FTC) Sets New 12-Month High - Here's What HappenedMarketBeatNASDAQ:FTCRead First Trust Large Cap Growth AlphaDEX Fund (NASDAQ:FTC) Sets New 12-Month High - Here's What Happened Featured Articles and Offers3 Defense Stocks Surging as Ukraine Tensions DeepenBy Dan Schmidt | October 5, 2025Arizona-made nanochips the new millionaire maker?From Banyan Hill Publishing (Ad)General Dynamics Hits New Highs: Why It Might Keep ClimbingBy Jeffrey Neal Johnson | October 2, 2025D-Wave Quantum (NYSE:QBTS) Downgraded to "Strong Sell" Rating by Zacks ResearchBy MarketBeat | October 8, 2025Is BigBear.ai the Next Palantir? By Gabriel Osorio-Mazilli | October 3, 2025Out of 18,347 Cryptocurrencies... This is the ONLY OneFrom Crypto 101 Media (Ad)Quantum Computing Stocks To Keep An Eye On - October 7thBy MarketBeat | October 9, 2025When Downgrades Create Opportunities: 3 Stocks to Watch NowBy Thomas Hughes | October 7, 2025 Sector NewsAerospace NewsArtificial Intelligence NewsAutomotive NewsConsumer Product NewsEnergy NewsFinancial Services NewsHealthcare NewsIndustrial NewsMedia NewsManufacturing NewsTechnology NewsTransportation NewsRetail News Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
